This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Northeast Regional Cancer Program | |
|---|---|
| Name | Northeast Regional Cancer Program |
| Formation | 20XX |
| Type | Nonprofit consortium |
| Headquarters | Example City, Example State |
| Region served | Northeastern United States |
| Leader title | Executive Director |
Northeast Regional Cancer Program
The Northeast Regional Cancer Program is a regional consortium providing cancer care coordination, clinical services, research facilitation, and community outreach across the Northeastern United States. The program partners with major hospitals, academic centers, and public health agencies to integrate oncology services, clinical trials, and prevention initiatives across urban and rural networks. It operates in collaboration with leading institutions to expand access to multidisciplinary oncology care and translational research.
The program traces its origins to regional cooperative efforts among Memorial Sloan Kettering Cancer Center, Dana–Farber Cancer Institute, Roswell Park Comprehensive Cancer Center, Yale Cancer Center, and Mount Sinai Health System to address disparities identified by the American Cancer Society, National Cancer Institute, Centers for Disease Control and Prevention, and state health departments. Early milestones included multi-institution agreements modeled on the National Comprehensive Cancer Network and the Cancer Moonshot initiatives, with pilot projects funded through partnerships resembling grants from the National Institutes of Health and awards such as the American Society of Clinical Oncology community grants. Over time the consortium expanded to include regional cancer centers, community hospitals, and academic departments from institutions like Columbia University Irving Medical Center, Johns Hopkins Medicine, and Rutgers University.
Governance is structured through a board including representatives from partner institutions such as NewYork-Presbyterian Hospital, Brigham and Women's Hospital, Hospital of the University of Pennsylvania, University of Vermont Medical Center, and regional public health agencies similar to the New York State Department of Health and Massachusetts Department of Public Health. Committees reflect expertise from departments including oncology divisions at Harvard Medical School, Perelman School of Medicine at the University of Pennsylvania, Icahn School of Medicine at Mount Sinai, and administrative oversight comparable to models used by the Association of American Cancer Institutes and the Commission on Cancer. Leadership roles draw from professionals affiliated with societies such as the American Society of Clinical Oncology, American Association for Cancer Research, and Society of Surgical Oncology.
Clinical services include multidisciplinary tumor boards, radiation oncology programs, surgical oncology networks, and survivorship care pathways developed with oncology departments at Memorial Sloan Kettering Cancer Center, Moffitt Cancer Center, Cleveland Clinic Taussig Cancer Institute, and Fox Chase Cancer Center. Programs cover screening initiatives aligned with guidelines from the U.S. Preventive Services Task Force, genetic counseling modeled on Myriad Genetics protocols, palliative care collaborations akin to Hospice and Palliative Care Organizations, and patient navigation services similar to those at City of Hope. Specialized clinics address breast cancer, lung cancer, colorectal cancer, hematologic malignancies, and pediatric oncology in cooperation with St. Jude Children's Research Hospital and Boston Children's Hospital.
The program facilitates multicenter clinical trials in partnership with cooperative groups such as the Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network, and Children's Oncology Group, leveraging trial infrastructures similar to the National Clinical Trials Network. Translational research collaborations connect investigators from Cold Spring Harbor Laboratory, The Jackson Laboratory, Broad Institute, and university laboratories at Yale University and Princeton University. Biobanking and genomics efforts follow standards used by the Clinical Laboratory Improvement Amendments and data-sharing practices seen in initiatives like the All of Us Research Program and the Cancer Genome Atlas. Investigator-initiated studies, phase I–III trials, and real-world evidence projects engage clinical investigators from Johns Hopkins Bloomberg School of Public Health and Columbia University Mailman School of Public Health.
Community outreach initiatives coordinate with nonprofit organizations such as the American Cancer Society, Susan G. Komen, Livestrong Foundation, and local chapters of the American Lung Association and Alzheimer's Association for awareness campaigns. Educational programming includes continuing medical education in collaboration with American Medical Association-accredited providers, patient education modeled after resources from National Cancer Institute, and school-based prevention efforts similar to campaigns by the Centers for Disease Control and Prevention. Tobacco cessation, HPV vaccination promotion, and screening outreach align with recommendations from the Advisory Committee on Immunization Practices and state immunization programs.
Member facilities span tertiary academic centers, community hospitals, and specialty clinics similar to Beth Israel Deaconess Medical Center, St. Joseph's Health, Strong Memorial Hospital, Baystate Medical Center, and regional cancer centers in metropolitan and rural settings. Satellite infusion centers, radiation suites, and diagnostic imaging hubs operate in partnership with radiology departments like those at Mayo Clinic and pathology services modeled after Laboratory Corporation of America. Telemedicine platforms extend services using technologies deployed by vendors adopted by institutions such as Kaiser Permanente and academic telehealth programs at Duke University School of Medicine.
Funding sources include competitive grants from agencies analogous to the National Institutes of Health, cooperative agreements with the Centers for Disease Control and Prevention, philanthropic support from foundations like Bill & Melinda Gates Foundation-type donors and local hospital foundations, and industry collaborations with pharmaceutical companies similar to Pfizer, Roche, Merck & Co., and biotechnology firms. Formal partnerships exist with academic consortia such as the NCI-designated Cancer Centers network, regional health information exchanges, and advocacy groups including Living Beyond Breast Cancer and LUNGevity Foundation.
Category:Cancer organizations in the United States